Importance Stereotactic body radiotherapy (SBRT) is widely used for stage I medically
inoperable non–small cell lung cancer (NSCLC), yet varied results from randomized clinical …

Introduction Definitive radiation therapy is considered standard therapy for medically
inoperable early-stage non-small cell lung cancer (NSCLC). However, for patients with …

A substantial portion of patients with advanced cancer cannot be cured, regardless of the
therapeutic methods employed. Hence, rational palliative causal treatment becomes crucial …

Purpose The use of stereotactic body radiation therapy for tumors in close proximity to the
central mediastinal structures has been associated with a high risk of toxicity. This study …

Stereotactic body radiation therapy (SBRT) of centrally located lung tumours is challenging,
given the risk of high-grade toxic effects for patients with a short tumour-bronchial distance …

This paper highlights developments in diagnostic and nonsurgical local treatment modalities
that have changed the management of early-stage lung cancer. These innovations aim to …

Lung cancer is one of the most common tumor types worldwide and the leading cause of
cancer-related deaths among both women and men [1]. There are two main types of lung …

Stereotactic body radiotherapy has been established as a viable treatment option for
inoperable early-stage non-small cell lung cancer or secondary lesions mainly in …

Purpose To use imaging data from stereotactic MR-guided online adaptive radiotherapy
(SMART) of ultracentral lung tumors (ULT) for development of a safe non-adaptive approach …

Background MRI-guidance may aid better discrimination between Organs at Risk (OARs)
and target volumes in proximity of the mediastinum. We report the first clinical experiences …